Pharmaceutical Supply – Varicella Vaccine (Finished Dose Vials)

The contract pertains to the supply of an FDA-approved, live, lyophilized varicella virus vaccine presented in finished dose vials. The vaccine must comply with current Good Manufacturing Practices (cGMP) and adhere to specific shelf-life requirements. Additionally, the product packaging and labeling are required to meet military standards, ensuring suitability for defense applications. The contract is issued as a subcontract by the Department of Defense under the Medical Supply Chain Pharmaceutical FSA, with the place of performance designated as Fort Wayne, zip code 46809-5000. The solicitation was posted on May 14, 2026, with a response deadline of May 20, 2026, indicating a short turnaround for submissions. The contract falls under the NAICS code 325412, related to pharmaceutical manufacturing. While details such as a solicitation number, type of set-aside, and specific contact information are not provided, the opportunity is accessible through the Defense Logistics Agency’s online platform, targeting suppliers capable of meeting stringent quality and military packaging specifications for the vaccine supply.